glp-1 digital health startups Dr. Craig Primack talks Hims & Hers launching its own offering as demand rises Long-term Success of GLP-1s Hinges

At the time of writing, phase II clinical trials are underway for some of these agents with negative results in INVOKE-2 trial (van Lengerich et al., 2023

The cosmetic-ingredient use of GHK-Cu represents a substantial and well-regulated application of the compound, governed by cosmetic ingredient regulatory frameworks distinct from pharmaceutical approval

PFOS and 4-phenylbutyrate (4-PBA) were purchased from Sigma Chemical (St

Yuan Q, Hong R, Ni Y, Jiang M, Liu J, Chen Z, Yang D (2024) Correlation between seminal plasma biochemical markers and semen parameters in idiopathic oligoasthenoteratospermia: identification of biomarkers for L-carnitine therapy

We cover the GLP-1 family that has become the modern standard, plus the non-GLP-1 options like Contrave